As a result of the COVID-19 pandemic, onsite audits to review quality control at contract manufacturers and in-person inspections by the FDA have become far more complicated, with industry and FDA adopting remote, virtual, and hybrid approaches to assess regulatory compliance. Join attorney Jeni Lamb Rogers today at 1 p.m. EST as she discusses trends and industry best practices.
Register here for the webinar that is free to members and $19 for non-members.